LSI Medience Corporation

Products & Services
R & D
Quality & Environmental Policy
- Quality Policy
- Environmental Policy
Corporate Profile

May.4,2018: Initiation of a Japanese Cancer Patient-derived Xenograft (J-PDX) Repository Establishment Program

Aug.3,2017: Provision of the first centralized clinical laboratory testing service in the Philippines

May.2,2014: Announcement of Business Alliance between Nikon and LSI Medience

Feb.6,2014: Mitsubishi Chemical Medience Corporation Announces New Company Name and New Head Office

Sep.17,2013: Mitsubishi Chemical Medience Starts Up Evaluating the Usefulness of Glycomics Analysis Services for Glycosylated Biologics and Biosimilars - Mitsubishi Chemical Medience Enters into an Exclusive License Agreement of Energy Resolved Oxonium Ion Monitoring (Erexim) Technology -

Jun.21,2013: Mitsubishi Chemical Medience and LabCorp Clinical Trials Announce Master Service Agreement to Offer Clients Greater Access to Global Central Lab Services

Oct.31,2011: Mitsubishi Chemical Medience Corporation launches PATHFAST Analyzer in U.S. market

Jun.17,2011: Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST cTnI-II (cardiac Troponin I) Test in U.S.

Copyright © LSI Medience Corporation. All Rights Reserved.